What's new

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised

Mar 25, 2025 - 17:04
 0
Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised
Human medicines European public assessment report (EPAR): EndolucinBeta, lutetium (177 Lu) chloride, Date of authorisation: 06/07/2016, Revision: 10, Status: Authorised
Read More

Tags:

Previous Article

Debería preocuparnos que Elon Musk vaya tras las bóvedas de semillas

Next Article

New England could connect 9.6 GW of offshore wind without new infrastructure: re...

Related Posts

Orphan designation: Rilzabrutinib Treatment of autoimmune haemolytic anaemia, 16/01/2025 Positive

Orphan designation: Rilzabrutinib Treatment of autoimmu...

Feb 20, 2025  0

Human medicines European public assessment report (EPAR): Mycapssa, octreotide, Date of authorisation: 02/12/2022, Status: Withdrawn

Human medicines European public assessment report (EPAR...

Mar 21, 2025  0

Veterinary medicines European public assessment report (EPAR): Hepizovac, epizootic haemorrhagic disease vaccine (inactivated), Status: Opinion

Veterinary medicines European public assessment report ...

Mar 14, 2025  0